Shearit LLC
Shearit LLC, based in Albuquerque, NM, is pioneering advancements in cerebrovascular disease treatment with its innovative product, Lamiflo. This groundbreaking non-pharmacologic solution offers a new approach to stroke management by being applicable in the pre-hospital phase, enhancing patient eligibility for thrombolysis and intra-arterial thrombectomy.
Focused on addressing acute large vessel occlusion strokes, Shearit aims to conduct rigorous clinical trials and secure FDA approval for Lamiflo, positioning it as a vital option for patients at risk of stroke both immediately and in the months that follow. With ongoing research and development, Shearit is committed to commercialization and improving outcomes for stroke patients worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


